Medical Devices
Few industries provide a broader scope of products than the medical devices sector. From ordinary eye glasses to extraordinary artificial hearts they assist in everyday living and staying alive every day. But it is a crowded and competitive business and companies often need experienced lawyers to ensure their products will one day help society. Our clients include start-up firms and industry leaders, private entities and public corporations. We've represented clients in trade secret disputes, negotiations with investors and patent infringements.
Representative Client Work
- Represented a group of venture firms in a series of multi-million dollar bridge financing transactions and an aggregate of $7.5 million late-stage financing for a life sciences company developing and marketing fluid-jet based surgical tools for the spine market
- Represented a life sciences start up company in a theft of trade secrets dispute relating to insulin pump technology
- Represented a group of venture capital investors in financing rounds aggregating $21.5 million in early-stage funding for a medical technology company developing an innovative, percutaneous approach for delivering heart valves to treat late-stage aortic stenosis
- Represented a foreign life sciences company in connection with a non-infringement opinion related to an implantable electronic device
- Represented a life sciences company in a patent infringement action relating to an automatic pole zero adjustment circuit for an ionizing radiation spectroscopy system
- Represented a publicly-traded life sciences company in connection with an inventorship and trade secret dispute relating to the development and use of magnetic resonance imaging contrast agents
- Represented a publicly-traded life sciences company in a dispute with a French multi-national corporation concerning license supply, marketing and distribution rights for superparamagnetic iron oxide nanoparticles
- Represented a start-up medical device company in all corporate matters, including the sale of one of its product lines to a public medical device company and the sale of its remaining business to another public company
Events
- November 5-6, 2012
2012 Life Sciences Summit
